Skip to content

LivaNova LIVN Allowance for Doubtful Accounts

Allowance for Doubtful Accounts at other companies

Abbott logo
AbbottABT
Haemonetics logo
HaemoneticsHAE
Medtronic logo
MedtronicMDT
ITG
Integer HoldingsITGR
ResMed logo
ResMedRMD
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's allowance for doubtful accounts?
LivaNova (LIVN) reported allowance for doubtful accounts of $10.31M in Q1 2026.
How has LivaNova's allowance for doubtful accounts changed year-over-year?
LivaNova's allowance for doubtful accounts decreased by 10.2% year-over-year, from $11.48M to $10.31M.
What is the long-term trend for LivaNova's allowance for doubtful accounts?
Over 5 years (2020 to 2025), LivaNova's allowance for doubtful accounts has grown at a 4.0% compound annual growth rate (CAGR), from $10.31M to $12.53M.